Source: MORNING AG CLIPS, 5/17/18

The recent European General Court ruling is disappointing and unfortunate. We stand by our past decision to challenge the European Commission’s decision-making process concerning our thiamethoxam technology, as it relied on a hypothetical risk to implement partial restrictions on neonicotinoid chemistries, outside legally approved regulation. Predictable regulatory frameworks and their consistent application by regulators enable companies like Syngenta to innovate and thus support European farmers and ultimately European consumers with locally produced, safe and affordable food.

For more of this story, click here.